Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
08/2004
08/12/2004WO2003106444A8 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
08/12/2004US20040156786 Paramagnetic complexes as contrast agents for magnetic resonance imaging; chelate compounds
08/11/2004EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
08/11/2004EP1443936A2 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds
08/11/2004EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
08/11/2004EP0877744B1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
08/11/2004CN1161345C 1,5-benzodiazepine derivatives ad CCK-A receptor agonists
08/10/2004US6774237 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/09/2004WO2004065591A1 Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals
08/09/2004CA2538147A1 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical
08/05/2004WO2004065390A1 Process and intermediates for the preparation of olanzapine
08/05/2004WO2004065382A1 Diazepanes derivatives useful as lfa inhibitors
08/05/2004WO2004037169A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/05/2004US20040152888 novel benzodiazepine derivatives
08/05/2004US20040152703 Controlling fertility; contraceptiives
08/05/2004US20040152693 For therapy of conditions associated with muscle spasms, epilepsy, acute and chronic forms of neurodegenerative diseases; for therapy andprophylaxis of acute and chronic inflammatory disorders
08/05/2004CA2509764A1 Diazepanes derivatives useful as lfa inhibitors
08/03/2004US6770771 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals
07/2004
07/29/2004WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/29/2004CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/28/2004EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/28/2004CN1516589A N-biphenylcarbonyl-anjd N-phenylpyridylcarbonyl substituted bi-and tricyclic azepines and diazepines as vasopressing agonists
07/27/2004US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
07/22/2004WO2004060376A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004CA2510050A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
07/21/2004EP1351942B1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
07/21/2004CN1514834A Cyclohexylphenyl vasopression agonists
07/20/2004CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
07/15/2004WO2004058164A2 Asthma and allergic inflammation modulators
07/15/2004US20040138208 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders
07/15/2004US20040138207 Antitumor agents
07/15/2004US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same
07/15/2004US20040138201 Prevent forming deposits of amyloid protein on nervous systems; Alzheimer's disease; Down syndrome
07/14/2004EP1436271A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
07/14/2004EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
07/14/2004CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated
07/13/2004US6762194 Quinolinone derivatives
07/08/2004WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
07/08/2004WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
07/08/2004WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists
07/08/2004WO2004056182A1 Pesticidal dibenzo(hetero)azepine derivatives
07/08/2004WO2003106628A3 Benzodiazepine inhibitors of mitochondial f¿1<f¿0? atp hydrolase and methods of inhibiting f¿1?f¿0? atp hydrolase
07/08/2004US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia.
07/08/2004US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
07/08/2004CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists
07/08/2004CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
07/07/2004EP1434588A2 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
07/06/2004US6759405 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
07/06/2004US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease
07/01/2004WO2004018058A3 Compounds, compositions, and methods
07/01/2004US20040127485 1,4! - diazepane -1- carboxylic acid derivatives process for their preparation and their use as tachykinin antagonists
06/2004
06/29/2004US6756511 Treating alzheimer's disease by preventing formation of insoluble amyloid beta and arresting its production
06/24/2004WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
06/24/2004US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds
06/23/2004EP1124556B1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders
06/23/2004CN1154644C Oxazolidinone derivatives and pharmaceutical compositions
06/23/2004CN1154640C Complex combinatorial chemical libraries encoded with tags
06/16/2004EP1427407A2 Fatty amine drug conjugates
06/16/2004EP1196418B1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
06/16/2004EP0960104B1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
06/15/2004US6750344 Monocyclic amine scaffold bearing at least two sites of diversity, cyclized to form bicyclic amine scaffolds; 7-amino-pyrrolo(1,2-a)pyrazin-4-one compounds
06/15/2004US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
06/10/2004US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
06/09/2004EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/08/2004US6747023 Sulfonyl derivatives
06/08/2004US6747022 Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same
06/02/2004EP1423122A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
06/02/2004EP1423107A2 Fatty alcohol drug conjugates
06/02/2004CN1501795A Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
05/2004
05/27/2004US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
05/26/2004EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
05/21/2004WO2004041286A1 Benzodiazepine derivatives for the treatment of diabetes mellitus
05/21/2004WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
05/21/2004CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
05/20/2004US20040097594 Sulfonamide inhibitors of aspartyl protease
05/20/2004US20040097545 Quinolinone derivatives
05/20/2004US20040097490 Novel heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as B-lactamase inhibitors and antibacterials
05/19/2004EP1273575B1 Diazepane derivatives or salts thereof
05/19/2004EP1021418B1 Substituted 2,3-benzodiazepin-4-ones and the use thereof
05/19/2004EP0717736B1 Phosphorus derivatives to treat aids
05/19/2004CN1150172C 1,5 benzodiazepine derviatives
05/13/2004US20040092510 Novel 2, 3 - benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
05/12/2004EP1417184A1 Composition for dyeing keratinous fibres containing a paraphenylenediamine substituted by a diazacycloheptane radical
05/12/2004EP1417183A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
05/12/2004CN1496362A Non-imidazole compounds as histamine H3 antagonists
05/06/2004WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands
05/06/2004WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/06/2004WO2003106428A8 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists
05/06/2004US20040086747 For light emission material of organic electroluminescent devices
05/06/2004EP1415990A1 Diazepan derivatives useful as factor X inhibitor
05/06/2004EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3
05/06/2004EP1163237B1 Amide derivatives
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
04/2004
04/29/2004WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004US20040082611 Novel sulfonyl derivatives
04/29/2004US20040082573 Anxiolytic agents with reduced sedative and ataxic effects
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 60